This suggests that ΔNp73 may have additional functions that could play a role not only at high/pathological levels of ΔNp73 in cancer therapy resistance and/or tumor aggressiveness but also in development by stimulating expression of TGF-β signaling targets via a novel, non-canonical pathway. The gene discussed is TGFB1; the disease is neoplasm.